| Apr 28, 2013
| 5:00 AM
The greatest dangers to liberty lurk in the insidious encroachment by men of zeal, well meaning but without understanding. — Louis D. Brandeis
Just a few words and little thought separate yet another stronghold of the American economy from ruin....
| Sep 22, 2012
| 11:52 AM
Every time a woman is tested for gene mutations linked to significantly higher rates of breast and ovarian cancer, her blood is sent to a lab in Utah.
That's because Salt Lake City-based Myriad Genetics Inc. owns the patents to the BRCA 1 and BRCA 2...
| Aug 28, 2011
| 6:22 PM
NEW YORK (Reuters) - Doctors are too quick to recommend expensive genetic counseling or testing for ovarian cancer, but at the same time often fail to refer women at high risk for the disease, government researchers said.
Ovarian cancer isn't very common...
| Jul 29, 2011
| 9:59 PM
CHICAGO (Reuters) - A U.S. federal appeals court affirmed the right of Myriad Genetics to patent two genes linked to breast cancer, overturning a lower court ruling that threatened a key element of the biotech business.
The U.S. Court of Appeals for...
| Jan 11, 2010
| 9:32 PM
Genetic research breakthroughs have come to be expected -- greeted with a sense of inevitability and the quiet assurance that science will ultimately puzzle out, then cure, human disease. But how those breakthroughs actually yield benefits is complicated....